Fulgent Genetics, Inc. (FLGT) vs OmniAb, Inc. (OABI)

A side-by-side comparison of Fulgent Genetics, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FLGT vs OABI

growth of $100 · dividends reinvested · last 5y
FLGT -74.3% (-23.8%/yr)OABI -49.6% (-12.8%/yr)OABI compounded faster over this window
50100Start $10020222023202420252026$26$50
FLGT OABI

FLGT vs OABI: by the numbers

  • •OABI is the larger company ($651M vs $588M market cap).
  • •Both run net losses; FLGT's is the smaller (-26.05% vs -115.18% net margin).
  • •Both shrank revenue over the past five years; OABI's decline was smaller (-4.31% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricFLGTOABI
P/S ratio1.8216.94
P/B ratio0.592.50

Profitability

MetricFLGTOABI
Gross margin35.58%-18.17%
Operating margin-28.23%-383.15%
Net margin-26.05%-115.18%
ROE-8.42%-17.01%
ROIC-11.80%-17.48%

Growth (annualized)

MetricFLGTOABI
Revenue CAGR (5Y)-18.66%-4.31%
Total return CAGR (5Y)-22.38%-13.17%

Frequently asked

Which has grown faster, FLGT or OABI?
Neither grew: over the past five years both shrank revenue, with OABI's decline the smaller — FLGT at a -18.66% CAGR versus OABI at -4.31%.
How have FLGT and OABI total returns compared?
Over the past 5 years, FLGT delivered -22.38% and OABI delivered -13.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.